SeRenade Parent-Child Music Class Program

Summary

SeRenade Parent-Child Music Class Program is a clinical trial^[1].

Key Facts

• SeRenade Parent-Child Music Class Program is in the country of United States^[2].
• SeRenade Parent-Child Music Class Program's instance of is recorded as clinical trial^[3].
• SeRenade Parent-Child Music Class Program's start time is recorded as +2018-05-15T00:00:00Z^[4].
• SeRenade Parent-Child Music Class Program's end time is recorded as +2020-05-31T00:00:00Z^[5].
• SeRenade Parent-Child Music Class Program's sponsor is recorded as Vanderbilt University Medical Center^[6].
• SeRenade Parent-Child Music Class Program's main subject is recorded as autism spectrum disorder^[7].
• SeRenade Parent-Child Music Class Program's number of participants is recorded as {'unit': '1', 'amount': '+68'}^[8].
• SeRenade Parent-Child Music Class Program's title is recorded as SeRenade Parent-Child Music Class Program for Families of Children With and Without ASD^[9].
• SeRenade Parent-Child Music Class Program's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q5151', 'amount': '+20'}^[10].
• SeRenade Parent-Child Music Class Program's ClinicalTrials.gov ID is recorded as NCT03560297^[11].
• SeRenade Parent-Child Music Class Program's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q5151', 'amount': '+72'}^[12].
• SeRenade Parent-Child Music Class Program's research intervention is recorded as nitrazepam^[13].
• SeRenade Parent-Child Music Class Program's research site is recorded as Vanderbilt University Medical Center^[14].
• SeRenade Parent-Child Music Class Program's principal investigator is recorded as Miriam D. Lense^[15].
• SeRenade Parent-Child Music Class Program's study type is recorded as interventional study^[16].